Spero Therapeutics
At Spero Therapeutics, it is our hope to advance novel treatments for rare diseases and MDR bacterial infections. Since our inception in
- November 8, 2024
bacterial infections, global, IT, Learn, novel treatments, QSOL Clients, rare diseases, Spero Therapeutics, targets
HIMSSCast: Web apps are ubiquitous in healthcare – and come with vulnerabilities
A web application takes advantage of standards developed for browsers to deliver information to users or other applications. Most of